Furthermore, data from bioinformatical analyses have implicated that ANAX1, CYR61, and VIM are mainly associated with the development of PAAD and GBM, while CEACAM1 and EPHA2 are associated with adrenocortical carcinoma. Here, CEACAM1 is linked to glioblastoma.